Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
National Institutes of Health
Pharma
BioNTech hit with 'notice of default' in COVID royalty dispute
U.S. officials are pressing the company to pay royalties linked to the commercialization of its lucrative Pfizer-partnered COVID-19 vaccine.
Eric Sagonowsky
Mar 25, 2024 9:35am
Patent conflict between U.S., Moderna could be headed for court
Nov 10, 2021 10:36am
Regeneron eyes prevention nod for COVID-19 antibody cocktail
Apr 12, 2021 10:01am
Regeneron shoots for longer Eylea dosing interval with NIH data
Apr 2, 2021 8:04am
Lilly nabs $375M government supply deal for COVID-19 drug
Oct 28, 2020 10:52am
NIH tests J&J, BMS and AbbVie drugs in new COVID-19 trial
Oct 16, 2020 11:06am
